READ : THIS DEAL HAS NO RELEVANCE VIS A VIS DRUG PRICING . THE PHARMACEUTICAL INDUSTRY , THE COST OF PHARMACEUTICALS TO THE HEALTHCARE SYSTEM HAS STAYED AT THE SAME PERCENTAGE , 10 TO 12 FOR A DECADE . I EXPECT IT TO STAY THERE . WHAT WE ' RE FOCUSED ON IS HOW DO WE BRING BENEFITS TO PEOPLE WHO HAVE ILLNESSES . HOW DO WE ENSURE THE SAFETY OF CHILDREN , THE SAFETY OF PEOPLE WHO HAVE DISEASES LIKE CANCER , ALZHEIMER ' S . THAT ' S WHAT IS IMPORTANT . THE HOPE THAT THAT RESEARCH OFFERS TO THE POPULATION .
